Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 2
2006 2
2013 3
2014 2
2015 5
2016 3
2018 1
2019 1
2020 2
2021 4
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Flow cytometry to detect bone marrow involvement by follicular lymphoma.
Aren M, Marce S, Jurado R, Tapia G, Puigdefabregues L, Raya M, Cortes M, Garcia-Caro M, Junca J, Mozas P, Viñets E, Cabezon M, Plensa E, Miljkovic M, Sancho JM, Navarro JT, Zamora L, Sorigue M. Aren M, et al. Among authors: marce s. Cytometry B Clin Cytom. 2022 Nov;102(6):427-439. doi: 10.1002/cyto.b.22098. Epub 2022 Oct 31. Cytometry B Clin Cytom. 2022. PMID: 36314855 Free article.
Diagnostic and prognostic contribution of targeted NGS in patients with triple-negative myeloproliferative neoplasms.
Acha P, Xandri M, Fuster-Tormo F, Palomo L, Xicoy B, Cabezón M, Marcé S, Granada I, Vela D, Sagüés M, Boque C, Plensa E, Pineda A, Feliu E, Solé F, Zamora L. Acha P, et al. Among authors: marce s. Am J Hematol. 2019 Oct;94(10):E264-E267. doi: 10.1002/ajh.25580. Epub 2019 Aug 6. Am J Hematol. 2019. PMID: 31321810 Free article. No abstract available.
Highly variable mutational profile of ASXL1 in myelofibrosis.
Sorigué M, Ribera JM, García O, Cabezón M, Vélez P, Marcé S, Xicoy B, Fernández C, Buch J, Cortes M, Plensa E, Gallardo D, Boqué C, Feliu E, Zamora L. Sorigué M, et al. Among authors: marce s. Eur J Haematol. 2016 Oct;97(4):331-5. doi: 10.1111/ejh.12731. Epub 2016 Jan 19. Eur J Haematol. 2016. PMID: 26714837
Co-existence of JAK2 V617F and CALR mutations in primary myelofibrosis.
Zamora L, Xicoy B, Cabezón M, Fernandez C, Marcé S, Velez P, Xandri M, Gallardo D, Millá F, Feliu E, Boqué C. Zamora L, et al. Among authors: marce s. Leuk Lymphoma. 2015;56(10):2973-4. doi: 10.3109/10428194.2015.1015124. Epub 2015 Mar 11. Leuk Lymphoma. 2015. PMID: 25686645 No abstract available.
Influence of Telomere Length on the Achievement of Deep Molecular Response With Imatinib in Chronic Myeloid Leukemia Patients.
Estrada N, Xicoy B, Beier F, Garcia O, Morales C, Boqué C, Sagüés M, Ventura Ferreira MS, Vallansot R, Marcé S, Cabezón M, Brümmendorf TH, Zamora L. Estrada N, et al. Among authors: marce s. Hemasphere. 2021 Nov 30;5(12):e657. doi: 10.1097/HS9.0000000000000657. eCollection 2021 Dec. Hemasphere. 2021. PMID: 34853825 Free PMC article.
Impact of BCR-ABL1 Transcript Type on Response, Treatment-Free Remission Rate and Survival in Chronic Myeloid Leukemia Patients Treated with Imatinib.
Marcé S, Xicoy B, García O, Cabezón M, Estrada N, Vélez P, Boqué C, Sagüés M, Angona A, Teruel-Montoya R, Ferrer-Marín F, Amat P, Hernández-Boluda JC, Ibarra MM, Anguita E, Cortés M, Fernández-Ruiz A, Fontanals S, Zamora L, On Behalf Of The Grupo Español de Leucemia Mieloide Crónica Gelmc. Marcé S, et al. J Clin Med. 2021 Jul 16;10(14):3146. doi: 10.3390/jcm10143146. J Clin Med. 2021. PMID: 34300312 Free PMC article.
e14a2 Transcript Favors Treatment-Free Remission in Chronic Myeloid Leukemia When Associated with Longer Treatment with Tyrosine Kinase Inhibitors and Sustained Deep Molecular Response.
Marcé S, Méndez A, Xicoy B, Estrada N, Cabezón M, Sturla AL, García MR, Angona A, Amat P, Escribano Serrat S, Scalzulli E, Morgades M, Senín A, Hernández-Boluda JC, Ferrer-Marín F, Anguita E, Cortés M, Plensa E, Breccia M, García-Gutierrez V, Zamora L; Grupo Español de Leucemia Mieloide Crónica (GELMC). Marcé S, et al. J Clin Med. 2024 Jan 29;13(3):779. doi: 10.3390/jcm13030779. J Clin Med. 2024. PMID: 38337473 Free PMC article.
FMOD expression in whole blood aids in distinguishing between chronic lymphocytic leukemia and other leukemic lymphoproliferative disorders. A pilot study.
Sorigue M, Junca J, Ferra C, Marce S, Ruiz-Xivillé N, Pinyol L, Cabezon M, Espasa A, Dominguez D, Lopez-Viaplana L, Ruiz R, Buch J, Plensa E, Mostacedo SZ, Aranda J, Vergara S, Raya M, Granada I, Tapia G, Navarro JT, Beà S, Zamora L. Sorigue M, et al. Among authors: marce s. Cytometry B Clin Cytom. 2020 Sep;98(5):421-428. doi: 10.1002/cyto.b.21890. Epub 2020 Jun 12. Cytometry B Clin Cytom. 2020. PMID: 32530577 Free article.
25 results